ETON
Eton Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
动量输入(同类管理人):
持有人广度 +8.3% ·
股份流向 +6.3% ·
净新建仓位 +7.7%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 69 | +17 | 8.71M | $315.16M | +19 | −1 |
| Q1 2026 | 53 | 0 | 6.86M | $169.02M | +7 | −7 |
| Q4 2025 | 53 | +3 | 7.09M | $119.84M | +3 | — |
| Q3 2025 | 13 | +1 | 6.27M | $136.34M | +1 | — |
| Q2 2025 | 9 | -2 | 4.42M | $63.03M | +1 | −3 |
| Q1 2025 | 8 | +2 | 1.18M | $15.27M | +3 | −1 |
| Q4 2024 | 6 | +2 | 854.61K | $11.39M | +2 | — |
| Q3 2024 | 3 | -1 | 376.73K | $2.26M | +1 | −2 |
| Q2 2024 | 4 | — | 363.35K | $1.20M | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 1.70M | +11.3% | $37.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 1.70M | +11.3% | $37.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 1.70M | +11.3% | $37.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 1.70M | +11.3% | $37.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 1.70M | +11.3% | $37.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 1.70M | +11.3% | $37.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | The Vanguard Group ✦ (被动) | 1.34M | +2.4% | $29.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | The Vanguard Group ✦ (被动) | 1.34M | +2.4% | $29.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 1.34M | +2.4% | $29.21M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 702.83K | — | $15.27M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | JPMorgan Chase ✦ | 702.83K | — | $15.27M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | JPMorgan Chase ✦ | 702.83K | — | $15.27M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | JPMorgan Chase ✦ | 702.83K | — | $15.27M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | JPMorgan Chase ✦ | 702.83K | — | $15.27M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | JPMorgan Chase ✦ | 702.83K | — | $15.27M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 586.05K | — | $12.73M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 586.05K | — | $12.73M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 586.05K | — | $12.73M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 586.05K | — | $12.73M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 586.05K | — | $12.73M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 586.05K | — | $12.73M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Geode Capital Management ✦ (被动) | 574.03K | -3.2% | $12.48M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 23 | Geode Capital Management ✦ (被动) | 574.03K | -3.2% | $12.48M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 24 | State Street Global Advisors ✦ (被动) | 438.44K | +35.7% | $9.53M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 324.62K | -20.0% | $7.05M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 286.42K | +33.5% | $6.22M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 190.16K | — | $4.13M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 190.16K | — | $4.13M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Wellington Management ✦ | 88.22K | +202.0% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 30 | Wellington Management ✦ | 88.22K | +202.0% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 31 | Wellington Management ✦ | 88.22K | +202.0% | $1.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 32 | Millennium Management ✦ | 15.86K | 新增 | $344,681 | 0.0% | New | 1 | SEC ↗ |
| 33 | T. Rowe Price ✦ | 13.52K | +5.3% | $294,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | Fidelity (FMR) ✦ | 5.69K | +1151.4% | $123,735 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 5.69K | +1151.4% | $123,735 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $344,681 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 115 持有人, 17.61M 股份, $424.10M 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Officer · 25.00K 股 · $1.63M
Officer, Director · 47.31K 股 · $2.85M
Officer, Director · 36.37K 股 · $2.22M
Officer, Director · 7.34K 股 · $456,085
Officer, Director · 8.98K 股 · $562,472
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论